Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myeloma
CAR T cell therapy demonstrates significant long-term success in treating myeloma, with a third of patients showing no detectable cancer after five years.
Mel Tottoh, a former footballer, faced a shocking myeloma diagnosis after months of pain, highlighting the importance of seeking timely medical advice.